Drug 'bevacizumab, rhuMAb-VEGF' details
Company: Genentech
Drug Name: bevacizumab, rhuMAb-VEGF
Current status: Available for drug pipeline subscribers only
Generic: Available for drug pipeline subscribers only
ICN: Available for drug pipeline subscribers only
Formulation: Available for drug pipeline subscribers only
Indication Group: Antineoplastic & immunomodulating agents
Indication Addressed:
Mode Of Action: Available for drug pipeline subscribers only
Last Updated: Q4 2007

Back to drug pipeline list Subscribe for drug pipeline

Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.